Cdx2 as a marker for neuroendocrine tumors of unknown primary sites

Lori A. Erickson, Bettina Papouchado, Haytham Dimashkieh, Shuya Zhang, Nobuki Nakamura, Ricardo V. Lloyd

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

The transcription factors CDX1 and CDX2 are homeobox genes that regulate development of the epithelium of the small and large intestine. A few studies have shown that Cdx2 protein expression is useful in the diagnosis of adenocarcinomas as well as neuroendocrine tumors of the small and large intestine. To examine the utility of Cdx2 in recognizing neuroendocrine tumors of unknown primary sites, we analyzed 224 primary and metastatic neuroendocrine tumors by immunohistochemistry. The specificity of the antibody reaction was confirmed by Western blotting. Cdx2 antibody stained all primary and most metastatic midgut carcinoid tumors. A few rectal and pulmonary carcinoids were positive, while gastric carcinoids were negative for Cdx2. One of five small cell carcinomas (20%) of the colon was positive for Cdx2, while all pulmonary small cell carcinomas were negative. Neuroendocrine tumors of the pituitary, parathyroid, medullary thyroid carcinomas, paragangliomas, pheochromocytomas and Merkel cell carcinomas were all negative for Cdx2. Western blot analysis of seven cases showed a 40 kDa band in both primary and metastatic midgut carcinoid tumors. These results indicate that Cdx2 can be very useful in recognizing metastatic neuroendocrine carcinomas of unknown primary sites, especially when they are derived from the small intestine.

Original languageEnglish (US)
Pages (from-to)247-252
Number of pages6
JournalEndocrine Pathology
Volume15
Issue number3
DOIs
StatePublished - Sep 2004

Fingerprint

Neuroendocrine Tumors
Carcinoid Tumor
Small Intestine
Small Cell Carcinoma
Large Intestine
Western Blotting
Merkel Cell Carcinoma
Neuroendocrine Carcinoma
Paraganglioma
Lung
Antibody Specificity
Homeobox Genes
Pheochromocytoma
Stomach
Colon
Adenocarcinoma
Epithelium
Immunohistochemistry
Antibodies
Proteins

Keywords

  • Carcinoid tumor
  • Cdx2
  • Neuroendocrine

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Pathology and Forensic Medicine

Cite this

Erickson, L. A., Papouchado, B., Dimashkieh, H., Zhang, S., Nakamura, N., & Lloyd, R. V. (2004). Cdx2 as a marker for neuroendocrine tumors of unknown primary sites. Endocrine Pathology, 15(3), 247-252. https://doi.org/10.1385/EP:15:3:247

Cdx2 as a marker for neuroendocrine tumors of unknown primary sites. / Erickson, Lori A.; Papouchado, Bettina; Dimashkieh, Haytham; Zhang, Shuya; Nakamura, Nobuki; Lloyd, Ricardo V.

In: Endocrine Pathology, Vol. 15, No. 3, 09.2004, p. 247-252.

Research output: Contribution to journalArticle

Erickson, LA, Papouchado, B, Dimashkieh, H, Zhang, S, Nakamura, N & Lloyd, RV 2004, 'Cdx2 as a marker for neuroendocrine tumors of unknown primary sites', Endocrine Pathology, vol. 15, no. 3, pp. 247-252. https://doi.org/10.1385/EP:15:3:247
Erickson LA, Papouchado B, Dimashkieh H, Zhang S, Nakamura N, Lloyd RV. Cdx2 as a marker for neuroendocrine tumors of unknown primary sites. Endocrine Pathology. 2004 Sep;15(3):247-252. https://doi.org/10.1385/EP:15:3:247
Erickson, Lori A. ; Papouchado, Bettina ; Dimashkieh, Haytham ; Zhang, Shuya ; Nakamura, Nobuki ; Lloyd, Ricardo V. / Cdx2 as a marker for neuroendocrine tumors of unknown primary sites. In: Endocrine Pathology. 2004 ; Vol. 15, No. 3. pp. 247-252.
@article{ea033a975f8c451187b9859ddb14b980,
title = "Cdx2 as a marker for neuroendocrine tumors of unknown primary sites",
abstract = "The transcription factors CDX1 and CDX2 are homeobox genes that regulate development of the epithelium of the small and large intestine. A few studies have shown that Cdx2 protein expression is useful in the diagnosis of adenocarcinomas as well as neuroendocrine tumors of the small and large intestine. To examine the utility of Cdx2 in recognizing neuroendocrine tumors of unknown primary sites, we analyzed 224 primary and metastatic neuroendocrine tumors by immunohistochemistry. The specificity of the antibody reaction was confirmed by Western blotting. Cdx2 antibody stained all primary and most metastatic midgut carcinoid tumors. A few rectal and pulmonary carcinoids were positive, while gastric carcinoids were negative for Cdx2. One of five small cell carcinomas (20{\%}) of the colon was positive for Cdx2, while all pulmonary small cell carcinomas were negative. Neuroendocrine tumors of the pituitary, parathyroid, medullary thyroid carcinomas, paragangliomas, pheochromocytomas and Merkel cell carcinomas were all negative for Cdx2. Western blot analysis of seven cases showed a 40 kDa band in both primary and metastatic midgut carcinoid tumors. These results indicate that Cdx2 can be very useful in recognizing metastatic neuroendocrine carcinomas of unknown primary sites, especially when they are derived from the small intestine.",
keywords = "Carcinoid tumor, Cdx2, Neuroendocrine",
author = "Erickson, {Lori A.} and Bettina Papouchado and Haytham Dimashkieh and Shuya Zhang and Nobuki Nakamura and Lloyd, {Ricardo V.}",
year = "2004",
month = "9",
doi = "10.1385/EP:15:3:247",
language = "English (US)",
volume = "15",
pages = "247--252",
journal = "Endocrine Pathology",
issn = "1046-3976",
publisher = "Humana Press",
number = "3",

}

TY - JOUR

T1 - Cdx2 as a marker for neuroendocrine tumors of unknown primary sites

AU - Erickson, Lori A.

AU - Papouchado, Bettina

AU - Dimashkieh, Haytham

AU - Zhang, Shuya

AU - Nakamura, Nobuki

AU - Lloyd, Ricardo V.

PY - 2004/9

Y1 - 2004/9

N2 - The transcription factors CDX1 and CDX2 are homeobox genes that regulate development of the epithelium of the small and large intestine. A few studies have shown that Cdx2 protein expression is useful in the diagnosis of adenocarcinomas as well as neuroendocrine tumors of the small and large intestine. To examine the utility of Cdx2 in recognizing neuroendocrine tumors of unknown primary sites, we analyzed 224 primary and metastatic neuroendocrine tumors by immunohistochemistry. The specificity of the antibody reaction was confirmed by Western blotting. Cdx2 antibody stained all primary and most metastatic midgut carcinoid tumors. A few rectal and pulmonary carcinoids were positive, while gastric carcinoids were negative for Cdx2. One of five small cell carcinomas (20%) of the colon was positive for Cdx2, while all pulmonary small cell carcinomas were negative. Neuroendocrine tumors of the pituitary, parathyroid, medullary thyroid carcinomas, paragangliomas, pheochromocytomas and Merkel cell carcinomas were all negative for Cdx2. Western blot analysis of seven cases showed a 40 kDa band in both primary and metastatic midgut carcinoid tumors. These results indicate that Cdx2 can be very useful in recognizing metastatic neuroendocrine carcinomas of unknown primary sites, especially when they are derived from the small intestine.

AB - The transcription factors CDX1 and CDX2 are homeobox genes that regulate development of the epithelium of the small and large intestine. A few studies have shown that Cdx2 protein expression is useful in the diagnosis of adenocarcinomas as well as neuroendocrine tumors of the small and large intestine. To examine the utility of Cdx2 in recognizing neuroendocrine tumors of unknown primary sites, we analyzed 224 primary and metastatic neuroendocrine tumors by immunohistochemistry. The specificity of the antibody reaction was confirmed by Western blotting. Cdx2 antibody stained all primary and most metastatic midgut carcinoid tumors. A few rectal and pulmonary carcinoids were positive, while gastric carcinoids were negative for Cdx2. One of five small cell carcinomas (20%) of the colon was positive for Cdx2, while all pulmonary small cell carcinomas were negative. Neuroendocrine tumors of the pituitary, parathyroid, medullary thyroid carcinomas, paragangliomas, pheochromocytomas and Merkel cell carcinomas were all negative for Cdx2. Western blot analysis of seven cases showed a 40 kDa band in both primary and metastatic midgut carcinoid tumors. These results indicate that Cdx2 can be very useful in recognizing metastatic neuroendocrine carcinomas of unknown primary sites, especially when they are derived from the small intestine.

KW - Carcinoid tumor

KW - Cdx2

KW - Neuroendocrine

UR - http://www.scopus.com/inward/record.url?scp=12844254318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12844254318&partnerID=8YFLogxK

U2 - 10.1385/EP:15:3:247

DO - 10.1385/EP:15:3:247

M3 - Article

C2 - 15640551

AN - SCOPUS:12844254318

VL - 15

SP - 247

EP - 252

JO - Endocrine Pathology

JF - Endocrine Pathology

SN - 1046-3976

IS - 3

ER -